Spatial transcriptome chip from Biomarker Technologies（BMKGENE）

Biomarker Technologies(BMK) is an industry-leading genomics service provider, headquartered in Beijing.In April 2022 , BMK launched the first microwell-based spatial transcriptome chip in China, which achieves a subcellular resolution. Through this chip, a comprehensive subcellular-level spatiotemporal dynamic expression map can be obtained, which can provide decision-making basis for disease diagnosis, treatment and drug development.